![Arnout Ploos van Amstel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Arnout Ploos van Amstel
Fondatore presso Moonlake Immunotherapeutics AG
Posizioni attive di Arnout Ploos van Amstel
Società | Posizione | Inizio | Fine |
---|---|---|---|
Khondrion BV
![]() Khondrion BV Pharmaceuticals: MajorHealth Technology Khondrion BV is a Dutch clinical-stage biopharmaceutical company that focuses on discovering and developing therapies for mitochondrial diseases. The company is based in Nijmegen, Netherlands, and was founded in 2012 by Jan Smeitink, who has been the CEO since then. The company's lead drug candidate, sonlicromanol, is a first-in-class, oral small molecule that targets key underlying mechanisms of primary mitochondrial disease. The compound has been granted orphan drug designations for the treatment of various mitochondrial diseases. Khondrion collaborates with a clinical and academic network and patient organizations internationally to accelerate the discovery and development of its potential medicines. | Direttore operativo | 10/12/2019 | - |
Moonlake Immunotherapeutics AG
![]() Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Direttore operativo | 01/01/2021 | - |
Fondatore | 01/01/2021 | - |
Storia della carriera di Arnout Ploos van Amstel
Precedenti posizioni note di Arnout Ploos van Amstel
Società | Posizione | Inizio | Fine |
---|---|---|---|
NOVARTIS AG | Corporate Officer/Principal | - | - |
Wyeth Pharmaceuticals LLC
![]() Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | - | - |
JATT ACQUISITION CORP | Direttore/Membro del Consiglio | - | - |
Independent Dir/Board Member | - | - |
Formazione di Arnout Ploos van Amstel
University of Groningen | Undergraduate Degree |
Statistiche
Distribuzione geografica
Paesi Bassi | 3 |
Svizzera | 3 |
Isole Cayman | 2 |
Posizioni
Chief Operating Officer | 2 |
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Settori
Health Technology | 5 |
Finance | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
NOVARTIS AG | Health Technology |
Aziende private | 4 |
---|---|
Khondrion BV
![]() Khondrion BV Pharmaceuticals: MajorHealth Technology Khondrion BV is a Dutch clinical-stage biopharmaceutical company that focuses on discovering and developing therapies for mitochondrial diseases. The company is based in Nijmegen, Netherlands, and was founded in 2012 by Jan Smeitink, who has been the CEO since then. The company's lead drug candidate, sonlicromanol, is a first-in-class, oral small molecule that targets key underlying mechanisms of primary mitochondrial disease. The compound has been granted orphan drug designations for the treatment of various mitochondrial diseases. Khondrion collaborates with a clinical and academic network and patient organizations internationally to accelerate the discovery and development of its potential medicines. | Health Technology |
JATT Acquisition Corp.
![]() JATT Acquisition Corp. Financial ConglomeratesFinance JATT Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Someit Sidhu on March 10, 2021 and is headquartered in George Town, Cayman Islands. | Finance |
Moonlake Immunotherapeutics AG
![]() Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
Wyeth Pharmaceuticals LLC
![]() Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |